It won’t take action against compounding pharmacies that make popular wellness products like BPC-157 and TB-500.
MarketWatch
Healthcare stocks are on their biggest hot streak in a generation. Think twice before chasing the rally.
The typically boring healthcare space has delivered a flash of excitement for investors in October, building on its gains from earlier in the year.
Bullish on Anthropic but don’t want to wait until the IPO? Here’s how you can invest today.
ETFs and other funds currently available to ordinary investors offer exposure to Anthropic.
Micron’s stock rises after SK Hynix earnings. Here’s its next major test.
Samsung’s results are the next big barometer for a memory-chip trade that’s springing back from recent lows.
11 bargain-priced stocks of companies that have huge growth potential over the next two years
These stocks trade at low price/earnings valuations, and the companies are projected to achieve very high revenue growth rates through 2028.
Vertiv earnings just sent an upbeat signal about AI ahead of Big Tech results
Vertiv’s big sales beat affirms that the AI buildout is accelerating.
The AI boom is starting to break time-tested stock-market signals
The relationship between gold and platinum used to be a reliable stock-market signal. Has artificial-intelligence spending caused it to short-circuit? Meanwhile, the Fed faces a big question of its own today.
SK Hynix delivered on third-quarter results — but the outlook is what really mattered to Wall Street and the AI trade
South Korea memory-chip giant says supply constraints will last through 2030.
The real way to tell if Amazon’s AI spending is paying off
Investors focus on Amazon’s cloud business, but the most important indicator might lie in the company’s warehouses.
Four reasons to start worrying about inflation — including the end of tariff refunds
Dennis DeBusschere, of 22V Research, said companies that previously used tariff refunds to ease cost pressures will increasingly hand down those higher costs to consumers.